Načítá se...
Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...
Uloženo v:
| Vydáno v: | Front Mater |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769812/ https://ncbi.nlm.nih.gov/pubmed/29349060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmats.2017.00027 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|